小鵬汽車(09868.HK)入股一徑科技 拓全固態激光雷達解決方案
據《天眼查》顯示,北京一徑科技有限公司今日發生工商變更,新增股東小鵬汽車(09868.HK)旗下廣州小鵬汽車投資諮詢合夥企業(有限合夥),註冊資本增至306.83萬元人民幣。
資料顯示,一徑科技致力於提供領先的全固態激光雷達解決方案,賦予無人駕駛汽車、機器人等人工智能應用可靠穩定、寬視角、遠距離及高分辨率的三維深度視覺能力,重點服務汽車主機廠、自動駕駛公司。目前量產落地的主攻方向為向特定區域各種場景的相關車輛提供整體激光雷達解決方案。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.